{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:08:58Z","timestamp":1747156138406,"version":"3.40.5"},"reference-count":5,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.berh.2024.101946","type":"journal-article","created":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T02:00:36Z","timestamp":1713060036000},"page":"101946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Response to kollas. Letter to the editor, \u201cproblems with opioids beyond misuse\u201d"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9532-6828","authenticated-orcid":false,"given":"Deeba","family":"Minhas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorna","family":"Kheirabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rezvan","family":"Ghaderpanah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Clauw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.berh.2024.101946_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical Practice guideline for prescribing opioids for pain - United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"issue":"1","key":"10.1016\/j.berh.2024.101946_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/jpm.2023.0251","article-title":"Effectiveness of long-term opioid therapy for chronic pain in an outpatient palliative medicine clinic","volume":"27","author":"Kollas","year":"2024","journal-title":"J Palliat Med"},{"issue":"6","key":"10.1016\/j.berh.2024.101946_bib3","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/ejp.1742","article-title":"Is opioid therapy for chronic non-cancer pain associated with a greater risk of all-cause mortality compared to non-opioid analgesics? A systematic review of propensity score matched observational studies","volume":"25","author":"Tolle","year":"2021","journal-title":"Eur J Pain"},{"issue":"9","key":"10.1016\/j.berh.2024.101946_bib4","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.2018.0899","article-title":"Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: the SPACE randomized clinical trial","volume":"319","author":"Krebs","year":"2018","journal-title":"JAMA"},{"issue":"10398","key":"10.1016\/j.berh.2024.101946_bib5","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(23)00404-X","article-title":"Opioid analgesia for acute low back pain and neck pain (the OPAL trial): a randomised placebo-controlled trial","volume":"402","author":"Jones","year":"2023","journal-title":"Lancet"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694224000172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694224000172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T14:28:18Z","timestamp":1724423298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694224000172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1521694224000172"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2024.101946","relation":{},"ISSN":["1521-6942"],"issn-type":[{"type":"print","value":"1521-6942"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Response to kollas. Letter to the editor, \u201cproblems with opioids beyond misuse\u201d","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2024.101946","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101946"}}